The rostral ventrolateral medulla (RVLM) is the primary sympathetic vasomotor center in the brainstem and contains C1 adrenergic neurons that are essential for maintaining baseline blood pressure and sympathetic tone. These neurons project directly to sympathetic preganglionic neurons in the intermediolateral cell column of the spinal cord, making them the final common pathway for supraspinal sympathetic control.
The RVLM receives input from the nucleus tractus solitarius (NTS), the hypothalamic pressor area, and higher cortical regions, integrating cardiovascular, respiratory, and emotional information to generate appropriate sympathetic responses. Dysfunction in RVLM neurons contributes to hypertension, autonomic failure in multiple system atrophy (MSA), and sleep-related breathing disorders.
| Property |
Value |
| Category |
Brainstem Autonomic Nervous System |
| Location |
Rostral ventrolateral medulla, rostral to the obex |
| Cell Types |
Sympathetic premotor (C1 adrenergic) |
| Primary Neurotransmitter |
Glutamate, Adrenaline |
| Key Markers |
VGLUT2, TH, C1 adrenergic neurons, Phox2b |
| Projection Target |
Intermediolateral cell column (IML), spinal cord |
| Afferent Inputs |
NTS, paraventricular nucleus, hypothalamus |
The RVLM is the primary determinant of sympathetic vasomotor tone:
- Baseline Tone: RVLM neurons maintain ~2-3 Hz firing at rest, setting vascular resistance
- Baroreceptor Reflex: Receives inhibitory input from the NTS during blood pressure rises
- Chemical Control: Sensitive to changes in PaO2, PaCO2, and pH
RVLM neurons control:
- Arterial Pressure: Via vasoconstriction of resistance vessels
- Heart Rate: Indirectly through cardiac sympathetic nerve activity
- Venous Return: Through splanchnic vein constriction
The RVLM integrates multiple inputs:
- Cardiovascular: Baroreceptor, chemoreceptor, cardiopulmonary afferents
- Respiratory: Coordinate sympathetic activity with breathing
- Emotional: Stress responses via amygdala and hypothalamus
¶ Location and Structure
The RVLM is located in the ventrolateral medulla oblongata, approximately 2-4 mm rostral to the obex. The region contains:
- C1 Neurons: Adrenergic neurons (~15% of RVLM neurons)
- Non-C1 Glutamatergic Neurons: Majority of presympathetic neurons
- Glycinergic Inhibitory Interneurons: Modulate output
RVLM neurons project to:
- Intermediolateral Cell Column (IML): Sympathetic preganglionic neurons (T1-L2)
- Nucleus of the Solitary Tract: Feedback modulation
- Paraventricular Nucleus of Hypothalamus: Integration
| Transmitter |
Role |
| Glutamate |
Main excitatory transmitter to IML |
| Adrenaline (C1) |
Modulatory, enhances sympathetic tone |
| Substance P |
Co-transmitter in some neurons |
| Neuropeptide Y |
Inhibits baroreceptor reflex |
RVLM hyperactivity contributes to essential hypertension:
- Increased sympathetic tone in ~50% of hypertensive patients
- Reduced baroreceptor sensitivity
- Possible role in resistant hypertension
MSA involves:
- Loss of RVLM neurons
- Severe autonomic failure
- Orthostatic hypotension
- Supine hypertension
RVLM dysfunction in OSA:
- Chronic intermittent hypoxia sensitizes RVLM
- Increased sympathetic activity during sleep
- Contributes to daytime hypertension
PD can involve autonomic dysfunction:
- RVLM involvement in some patients
- Contributes to orthostatic hypotension
- May relate to non-motor symptoms
The C1 neurons in the RVLM are unique:
- Express tyrosine hydroxylase (TH)
- Release adrenaline as a co-transmitter
- Express glucocorticoid receptors
- Sensitive to hypoxia
In hypertension:
- Reduced GABAergic Inhibition: From NTS and baroreceptor input
- Increased Glutamatergic Excitation: From hypothalamus and cortex
- Angiotensin II Sensitization: Within the RVLM
- Oxidative Stress: In RVLM neurons
| Drug Class |
RVLM Mechanism |
| Beta-blockers |
Reduce central sympathetic output |
| Alpha-2 agonists |
Inhibit RVLM firing |
| Centrally acting agents |
Clonidine, methyldopa |
| ACE inhibitors |
Reduce angiotensin II in RVLM |
Experimental approaches:
- RVLM DBS for refractory hypertension
- May reduce sympathetic tone
- Still experimental
- CPAP reduces RVLM sympathetic overactivity
- Lowering sympathetic tone improves outcomes
The study of Rostral Ventrolateral Medulla Sympathetic Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Dampney RA. Functional organization of central pathways regulating the cardiovascular system. Physiol Rev. 1994;74(2):323-364. PMID:8171117
- Guyenet PG. The sympathetic control of blood pressure. Nat Rev Neurosci. 2006;7(5):335-346. PMID:16760914
- Schreihofer AM, Sved AF. Use of glutamate antagonists in the study of the regulation of blood pressure. Clin Exp Pharmacol Physiol. 1996;23(12):1065-1071. PMID:8972391
- Low PA, et al. Autonomic nervous system disorders. Lancet. 2005;365(9466):1253-1260. PMID:15811456
- Somogyi P, et al. Adrenergic neurons in the rostral ventrolateral medulla. Prog Brain Res. 1996;107:49-79. PMID:8782524
- Javaheri S, et al. Sleep apnea and cardiovascular disease. Circulation. 2008;118(10):1080-1111. PMID:18725477